122 results on '"Casali, P.G."'
Search Results
2. Outcome improvement with chemotherapy and radiotherapy in primary, localized, radiation-associated angiosarcoma of the breast region: a retrospective case series analysis
3. Epithelioid hemangioendothelioma, an ultra-rare cancer: a consensus paper from the community of experts
4. Final analysis of the randomized trial on imatinib as an adjuvant in localized gastrointestinal stromal tumors (GIST) from the EORTC Soft Tissue and Bone Sarcoma Group (STBSG), the Australasian Gastro-Intestinal Trials Group (AGITG), UNICANCER, French Sarcoma Group (FSG), Italian Sarcoma Group (ISG), and Spanish Group for Research on Sarcomas (GEIS)☆
5. Clinical prognostic factors in advanced epithelioid haemangioendothelioma: a retrospective case series analysis within the Italian Rare Cancers Network
6. Gastrointestinal stromal tumours: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up
7. The sacral chordoma margin
8. Bone sarcomas: ESMO–PaedCan–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
9. Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
10. Gastrointestinal stromal tumours: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
11. Gastrointestinal stromal tumours
12. Best practices for the management of local-regional recurrent chordoma: a position paper by the Chordoma Global Consensus Group
13. Patient-derived solitary fibrous tumour xenografts predict high sensitivity to doxorubicin/dacarbazine combination confirmed in the clinic and highlight the potential effectiveness of trabectedin or eribulin against this tumour
14. Correlation between radiological assessment and histopathological diagnosis in retroperitoneal tumors: Analysis of 291 consecutive patients at a tertiary reference sarcoma center
15. Long-term follow-up of patients with GIST undergoing metastasectomy in the era of imatinib – Analysis of prognostic factors (EORTC-STBSG collaborative study)
16. Sporadic desmoid-type fibromatosis: a stepwise approach to a non-metastasising neoplasm—a position paper from the Italian and the French Sarcoma Group
17. The current and future role of the medical oncologist in the professional care for cancer patients: a position paper by the European Society for Medical Oncology (ESMO)
18. Soft tissue and visceral sarcomas
19. Sunitinib malate in solitary fibrous tumor (SFT)
20. Adjuvant therapy in primary GIST: state-of-the-art
21. Frontline extended surgery is associated with improved survival in retroperitoneal low- to intermediate-grade soft tissue sarcomas
22. Sunitinib in advanced alveolar soft part sarcoma: evidence of a direct antitumor effect
23. Primary extremity soft tissue sarcomas: outcome improvement over time at a single institution
24. Soft tissue sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
25. Gastrointestinal stromal tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
26. Post-imatinib surgery in advanced/metastatic GIST: is it worthwhile in all patients?
27. Response to imatinib plus sirolimus in advanced chordoma
28. Trabectedin in myxoid liposarcomas (MLS): a long-term analysis of a single-institution series
29. Ewing's sarcoma of the bone: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
30. Osteosarcoma: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
31. Soft tissue sarcomas: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
32. Gastrointestinal stromal tumours: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
33. Preoperative imatinib mesylate for unresectable or locally advanced primary gastrointestinal stromal tumors (GIST)
34. Soft tissue sarcomas: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
35. Gastrointestinal stromal tumors: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
36. Phase II, open-label study of PTK787/ZK222584 for the treatment of metastatic gastrointestinal stromal tumors resistant to imatinib mesylate
37. Phase II study on lapatinib in advanced EGFR-positive chordoma†
38. Gastrointestinal stromal tumours: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up.
39. The impact of chemotherapy on survival of patients with extremity and trunk wall soft tissue sarcoma: revisiting the results of the EORTC-STBSG 62931 randomised trial
40. Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up (vol 29, pg 51, 2018)
41. Sacro-coccygeal chordoma: Diagnosis and treatment review
42. Quality of Surgery and Outcome in Extra-Abdominal Aggressive Fibromatosis: A Series of Patients Surgically Treated at a Single Institution
43. 'Rare cancers': not all together in clinical studies!
44. Global cancer control: Responding to the growing burden, rising costs and inequalities in access
45. Management of Recurrent Retroperitoneal Sarcoma (RPS) in the Adult: A Consensus Approach from the Trans-Atlantic RPS Working Group (vol 23, pg 3531, 2016)
46. Data protection and research in the European Union: a major step forward, with a step back.
47. 1547P Trabectedin in soft-tissue sarcoma patients in Italy: Analysis of real-world data from a national registry
48. 1667TiP A phase II, single arm study of avelumab in combination with axitinib in patients with unresectable/metastatic gastrointestinal stromal tumor after failure of standard therapy - AXAGIST
49. 1625MO ABCB1/P-glycoprotein (Pgp) expression as stratification factor for treatment of patients with non metastatic extremity high grade osteosarcoma: An Italian Sarcoma Group (ISG) multicentric prospective trial (ISG/OS-2)
50. 604TiP ON-TRK: A non-interventional study of larotrectinib in patients with TRK fusion cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.